Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015;45(12):2619-29.
doi: 10.1017/S0033291715000562. Epub 2015 May 12.

Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial

P Gardner-Sood  1 , J Lally  1 , S Smith  2 , Z Atakan  1 , K Ismail  2 , K E Greenwood  3 , A Keen  2 , C O'Brien  2 , O Onagbesan  4 , C Fung  2 , E Papanastasiou  2 , J Eberhard  5 , A Patel  6 , R Ohlsen  7 , D Stahl  8 , A David  2 , D Hopkins  9 , R M Murray  1 , F Gaughran  10 ; IMPaCT team
Affiliations
Randomized Controlled Trial

Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial

P Gardner-Sood et al. Psychol Med. 2015.

Erratum in

Abstract

Background: The aims of the study were to determine the prevalence of cardiometabolic risk factors and establish the proportion of people with psychosis meeting criteria for the metabolic syndrome (MetS). The study also aimed to identify the key lifestyle behaviours associated with increased risk of the MetS and to investigate whether the MetS is associated with illness severity and degree of functional impairment.

Method: Baseline data were collected as part of a large randomized controlled trial (IMPaCT RCT). The study took place within community mental health teams in five Mental Health NHS Trusts in urban and rural locations across England. A total of 450 randomly selected out-patients, aged 18-65 years, with an established psychotic illness were recruited. We ascertained the prevalence rates of cardiometabolic risk factors, illness severity and functional impairment and calculated rates of the MetS, using International Diabetes Federation (IDF) and National Cholesterol Education Program Third Adult Treatment Panel criteria.

Results: High rates of cardiometabolic risk factors were found. Nearly all women and most men had waist circumference exceeding the IDF threshold for central obesity. Half the sample was obese (body mass index ≥ 30 kg/m2) and a fifth met the criteria for type 2 diabetes mellitus. Females were more likely to be obese than males (61% v. 42%, p < 0.001). Of the 308 patients with complete laboratory measures, 57% (n = 175) met the IDF criteria for the MetS.

Conclusions: In the UK, the prevalence of cardiometabolic risk factors in individuals with psychotic illnesses is much higher than that observed in national general population studies as well as in most international studies of patients with psychosis.

Keywords: Metabolic syndrome; physical health; psychotic disorder; schizophrenia; severe mental illnesses.

PubMed Disclaimer

References

    1. Alberti KG, Zimmet P, Shaw J (2005). The metabolic syndrome – a new worldwide definition. Lancet 366, 1059–1062. - PubMed
    1. Alberti KG, Zimmet P, Shaw J (2006). Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Medicine 23, 469–480. - PubMed
    1. Alvarez-Jimenez M, Martinez-Garcia O, Perez-Iglesias R, Ramirez ML, Vazquez-Barquero JL, Crespo-Facorro B (2010). Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial. Schizophrenia Research 116, 16–19. - PubMed
    1. American Psychiatric Association (2002). Multiaxial assessment In Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revised (DSM-IV-TR) APA: Arlington, VA.
    1. Arango C, Bobes J, Kirkpatrick B, Garcia-Garcia M, Rejas J (2011). Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: findings from the CLAMORS study. European Neuropsychopharmacology 21, 867–875. - PubMed

Publication types

MeSH terms

Substances

Associated data